Որոնման արդյունքները - Pablo Forte
- Ցուցադրվում են 1 - 2 արդյունքները 2
-
1
Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects Robert S. Palmer, Jukka Maenpää, Alexandra Jauhiainen, Bengt Larsson, John Mo, Muir Russell, James Root, Susanne Prothon, Ligia Chialda, Pablo Forte, Torbjörn Egelrud, Kristina Stenvall, Philip Gardiner
Հրապարակվել է 2018Artigo -
2
Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab)... Pablo Forte-Soto, Muna Albayaty, Dennis Brooks, Rosalinda H. Arends, John Tillinghast, Anastasia A. Aksyuk, Jérôme Bouquet, Cecil Chen, Asfiha Gebre, Robert Kubiak, Venkatesh Pilla Reddy, Seth Seegobin, Katie Streicher, Alison Templeton, Mark T. Esser
Հրապարակվել է 2023Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Adverse effect
Immunology
Internal medicine
Medicine
Pharmacokinetics
Pharmacology
Tolerability
2019-20 coronavirus outbreak
Antibody
Biochemistry
Biology
COPD
Coronavirus
Coronavirus disease 2019 (COVID-19)
Diabetes mellitus
Dipeptidyl peptidase-4
Disease
Elastase
Endocrinology
Enzyme
Infectious disease (medical specialty)
Inflammation
Lung
Monoclonal antibody
Neutrophil elastase
Outbreak
Pharmacodynamics
Proteases
Respiratory system
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)